normative

FDA should reject trials with irrelevant controls

The FDA is legally free to decline approval for drugs tested only against a control arm that is not best practice or relevant standard of care, since such a 'horse race' is rigged, yet over the last 20-30 years it has drifted consistently toward saying yes; it should simply refuse to approve drugs based on such flawed trials.

normativepending

Speaker

Russ Roberts

Evidence Quote

“what we have seen over the last 20, 30 years is a consistent drift towards saying yes”

Source

Vinay Prasad on Cancer Drugs, Medical Ethics, and Malignant— EconTalk
Created: 6/13/2026, 12:28:36 AM

Your notes

Loading notes...